Inventor

PONCELET VIRGINIE SOPHIE

FR37 patents

⚠️ This page may combine multiple inventors who share the name “PONCELET VIRGINIE SOPHIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PONCELET VIRGINIE SOPHIE

JANSSEN PHARMACEUTICA NV

Amino-derivatives as novel inhibitors of histone deacetylase

Sulfonyl-derivatives as novel inhibitors of histone deacetylase

Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles

Sulfonyl-derivatives as novel inhibitors or histone deacetylase

Sulfonyl-Derivatives as novel inhibitors of histone deacetylase

Pyrido-and pyrimidopyrimidine derivatives as anti-profilerative agents

Exo-aza spiro inhibitors of menin-MLL interaction

Inhibitors of the interaction between MDM2 and P53

Intermediate compounds in the preparation of farnnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N-or C linked imidazoles

Amino-derivatives as novel inhibitors of histone deacetylase

Amino-derivatives as novel inhibitors of histone deacetylase

Farnesyl transferase inhibiting benzoheterocyclic derivatives

Macrocyclic quinazole derivatives and their use as MTKI

Macrocyclic quinazole derivatives and their use as MTKI

Substituted azaindoline derivatives as NIK inhibitors

Substituted cyanoindoline derivatives as NIK inhibitors

Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors

Pyrido and pyrimidopyrimidine derivatives as anti-profilerative agents

Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors

Imidazopyridazine derivatives as PI3KB inhibitors

ASTEX THERAPEUTICS LTD

Pteridines as FGFR inhibitors

Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors

Substituted quinoxalines as FGFR kinase inhibitors

Substituted quinoxalines as FGFR kinase inhibitors

Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors

Quinazolinone derivatives useful as FGFR kinase modulators

Pteridines as FGFR inhibitors

EMELEN KRISTOF VAN

Sulfonyl-derivatives as novel inhibitors of histone deacetylase

Sulfonyl-derivatives as novel or histone deacetylase

Sulfonyl-derivatives as novel inhibitors of histone deacetylase

VIALARD JORGE EDUARDO

Quinolinone derivatives as PARP and TANK inhibitors

Quinolinone derivatives as PARP and tank inhibitors

STORCK PIERRE-HENRI

Inhibitors of the interaction between MDM2 and p53

ANGIBAUD PATRICK RENE

Amino-derivatives as novel inhibitors of histone deacetylase

FREYNE EDDY JEAN EDGARD

Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agents

PONCELET VIRGINIE SOPHIE

Inhibitors of the interaction between MDM2 and P53

PONCELET ALAIN PHILIPPE

Substituted phenylenediamines as inhibitors of the interaction between MDM2 and P53